CDH1 and urinary bladder cancer: The most interesting finding for bladder cancer, which is in accordance with the presented results for prostate cancer, was the fact that patients at risk of early relapse of superficial bladder tumours had significantly elevated serum levels of soluble e-cadherin at presentation (Griffiths et al, 1996).